Reaction
Bone Metabolism Disorder reporting signals
As of the last recalculation, Bone Metabolism Disorder appears in 298 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is ABACAVIR SULFATE (PRR 97.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Abacavir Sulfate | 13 | 97.4 | 97.5 |
| Tenofovir Disoproxil Fumarate Tablets | 8 | 66.5 | 66.5 |
| Nevirapine | 8 | 63.6 | 63.7 |
| Lamivudine Oral | 16 | 46.6 | 46.7 |
| Tenofovir Disoproxil Fumarate | 20 | 45.2 | 45.3 |
| Lamivudine | 17 | 40.7 | 40.7 |
| Dolutegravir Sodium | 5 | 39.4 | 39.4 |
| Polatuzumab Vedotin | 5 | 36.4 | 36.4 |
| Vigabatrin | 7 | 34.3 | 34.3 |
| Emtricitabine And Tenofovir Alafenamide | 5 | 31.3 | 31.3 |
| Romosozumab-Aqqg | 3 | 15.6 | 15.6 |
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 4 | 9.1 | 9.1 |